These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26468327)

  • 1. The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.
    Sidman RL; Li J; Lawrence M; Hu W; Musso GF; Giordano RJ; Cardó-Vila M; Pasqualini R; Arap W
    Sci Transl Med; 2015 Oct; 7(309):309ra165. PubMed ID: 26468327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoB antibody alters retinal vascularization in models of murine retinopathy.
    Almonte-Baldonado R; Bravo-Nuevo A; Gerald D; Benjamin LE; Prendergast GC; Laury-Kleintop LD
    J Cell Biochem; 2019 Jun; 120(6):9381-9391. PubMed ID: 30536763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol, an Inhibitor Binding to VEGF, Restores the Pathology of Abnormal Angiogenesis in Retinopathy of Prematurity (ROP) in Mice: Application by Intravitreal and Topical Instillation.
    Hu WH; Zhang XY; Leung KW; Duan R; Dong TT; Qin QW; Tsim KW
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
    Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rice Bran and Vitamin B6 Suppress Pathological Neovascularization in a Murine Model of Age-Related Macular Degeneration as Novel HIF Inhibitors.
    Ibuki M; Lee D; Shinojima A; Miwa Y; Tsubota K; Kurihara T
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.
    Shih SC; Ju M; Liu N; Smith LE
    J Clin Invest; 2003 Jul; 112(1):50-7. PubMed ID: 12840058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
    Dal Monte M; Ristori C; Cammalleri M; Bagnoli P
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3596-606. PubMed ID: 19324858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies.
    Dai C; Webster KA; Bhatt A; Tian H; Su G; Li W
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats.
    Nakano A; Nakahara T; Mori A; Ushikubo H; Sakamoto K; Ishii K
    Exp Eye Res; 2016 Feb; 143():120-31. PubMed ID: 26500193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of retinal neovascularization by gold nanoparticles via suppression of VEGFR-2 activation.
    Kim JH; Kim MH; Jo DH; Yu YS; Lee TG; Kim JH
    Biomaterials; 2011 Mar; 32(7):1865-71. PubMed ID: 21145587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy for the treatment of ocular neovascularization.
    Bradley J; Ju M; Robinson GS
    Angiogenesis; 2007; 10(2):141-8. PubMed ID: 17372853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of neovascularization and expression shift of pro-/anti-angiogenic vascular endothelial growth factor isoforms after intravitreal bevacizumab injection in oxygen-induced-retinopathy mouse model.
    Shi X; Zhao M; Xie WK; Liang JH; Miao YF; DU W; Li XX
    Chin Med J (Engl); 2013 Jan; 126(2):345-52. PubMed ID: 23324288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin.
    Sarlos S; Rizkalla B; Moravski CJ; Cao Z; Cooper ME; Wilkinson-Berka JL
    Am J Pathol; 2003 Sep; 163(3):879-87. PubMed ID: 12937129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration.
    Yazdi MH; Faramarzi MA; Nikfar S; Falavarjani KG; Abdollahi M
    Expert Opin Biol Ther; 2015; 15(9):1349-58. PubMed ID: 26076760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinopathy of prematurity.
    Chen J; Smith LE
    Angiogenesis; 2007; 10(2):133-40. PubMed ID: 17332988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-VEGF agents for age-related macular degeneration.
    Ozkiris A
    Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.